DFS
59
2
IP
36
2
UA
33
4
MPC
30
-9
KSS
34
6
ICE
49
-4
PBI
49
10
WRK
73
8
DVA
83
2
AIG
56
2
URI
60
2
NWSA
67
2
ZTS
65
27
M
48
6
AMG
38
2
MAR
47
2
APA
39
-7
NEM
55
2
TSCO
50
-6
WYNN
41
3
DFS
59
2
IP
36
2
UA
33
4
MPC
30
-9
KSS
34
6
ICE
49
-4
PBI
49
10
WRK
73
8
DVA
83
2
AIG
56
2
URI
60
2
NWSA
67
2
ZTS
65
27
M
48
6
AMG
38
2
MAR
47
2
APA
39
-7
NEM
55
2
TSCO
50
-6
WYNN
41
3
Financhill
Back

Terns Pharmaceuticals Quote, Financials, Valuation and Earnings

This trade could move overnight Thursday!

Access my free presentation on these overnight trades right here
Sell
47

TERN
Terns Pharmaceuticals

Last Price:
5.44
Seasonality Move:
-31.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Stock Market Legend Shares Biggest Prediction Ever:

Click Here to See

Terns Pharmaceuticals Price Quote

$5.44
+0.14 (+2.64%)
(Updated: May 3, 2024 at 6:55 PM ET)

Terns Pharmaceuticals Key Stats

Sell
47
Terns Pharmaceuticals (TERN) is a Sell
Day range:
$5.08 - $5.34
52-week range:
$3.26 - $13.51
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.34%
Volume:
466.9K
Avg. volume:
844.1K
1-year change:
-56.2%
Market cap:
$342.7M
Revenue:
$0
EPS:
$-1.27

How Much Does Terns Pharmaceuticals Make?

Data Unavailable

Is Terns Pharmaceuticals Growing As A Company?

Data Unavailable

Terns Pharmaceuticals Stock Price Performance

What Is Terns Pharmaceuticals 52-Week High & Low?

Terns Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Terns Pharmaceuticals?

Is Terns Pharmaceuticals Cash Flow Positive?

  • What Is TERN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$67.4M
  • What Is Terns Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $42M
  • What Is Terns Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$38M

Terns Pharmaceuticals Return On Invested Capital

Data Unavailable

Terns Pharmaceuticals Earnings Date & Stock Price

Terns Pharmaceuticals Competitors

Terns Pharmaceuticals Dividend Yield

Data Unavailable

Terns Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0.74%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 14.21
Upside from Last Price: 168.19%

Major Shareholders

  • How many TERN shares are owned by institutional investors?
    82.9M TERN shares are owned by institutional investors
  • How many TERN shares are owned by insiders?
    633.5K TERN shares are owned by insiders